Publication: Ex Vivo Susceptibility of Plasmodium falciparum to antimalarial drugs in western, Northern, and Eastern Cambodia, 2011-2012: Association with molecular markers
Issued Date
2013-11-01
Resource Type
ISSN
10986596
00664804
00664804
Other identifier(s)
2-s2.0-84885941960
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Antimicrobial Agents and Chemotherapy. Vol.57, No.11 (2013), 5277-5283
Suggested Citation
Pharath Lim, Dalin Dek, Vorleak Try, Richard T. Eastman, Sophy Chy, Sokunthea Sreng, Seila Suon, Sivanna Mao, Chantha Sopha, Baramey Sam, Elizabeth A. Ashley, Olivo Miotto, Arjen M. Dondorp, Nicholas J. White, Xin Zhuan Su, Meng Chuor Char, Jennifer M. Anderson, Chanaki Amaratunga, Didier Menard, Rick M. Fairhurst Ex Vivo Susceptibility of Plasmodium falciparum to antimalarial drugs in western, Northern, and Eastern Cambodia, 2011-2012: Association with molecular markers. Antimicrobial Agents and Chemotherapy. Vol.57, No.11 (2013), 5277-5283. doi:10.1128/AAC.00687-13 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/32098
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Ex Vivo Susceptibility of Plasmodium falciparum to antimalarial drugs in western, Northern, and Eastern Cambodia, 2011-2012: Association with molecular markers
Author(s)
Abstract
In 2008, dihydroartemisinin (DHA)-piperaquine (PPQ) became the first-line treatment for uncomplicated Plasmodium falciparum malaria in western Cambodia. Recent reports of increased treatment failure rates after DHA-PPQ therapy in this region suggest that parasite resistance to DHA, PPQ, or both is now adversely affecting treatment. While artemisinin (ART) resistance is established in western Cambodia, there is no evidence of PPQ resistance. To monitor for resistance to PPQ and other antimalarials, we measured drug susceptibilities for parasites collected in 2011 and 2012 from Pursat, Preah Vihear, and Ratanakiri, in western, northern, and eastern Cambodia, respectively. Using a SYBR green I fluorescence assay, we calculated the ex vivo 50% inhibitory concentrations (IC50s) of 310 parasites to six antimalarials: chloroquine (CQ), mefloquine (MQ), quinine (QN), PPQ, artesunate (ATS), and DHA. Geometric mean IC50s (GMIC50s) for all drugs (except PPQ) were significantly higher in Pursat and Preah Vihear than in Ratanakiri (P ≤ 0.001). An increased copy number of P. falciparum mdr1 (pfmdr1), an MQ resistance marker, was more prevalent in Pursat and Preah Vihear than in Ratanakiri and was associated with higher GMIC50s for MQ, QN, ATS, and DHA. An increased copy number of a chromosome 5 region (X5r), a candidate PPQ resistance marker, was detected in Pursat but was not associated with reduced susceptibility to PPQ. The ex vivo IC50and pfmdr1 copy number are important tools in the surveillance of multidrug-resistant (MDR) parasites in Cambodia. While MDR P. falciparum is prevalent in western and northern Cambodia, there is no evidence for PPQ resistance, suggesting that DHA-PPQ treatment failures result mainly from ART resistance. Copyright © 2013, American Society for Microbiology.